Dr. Blankson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
600 N Wolfe St
Baltimore, MD 21287Phone+1 410-955-9441
Education & Training
- Johns Hopkins UniversityFellowship, Infectious Disease, 1998 - 2002
- Johns Hopkins UniversityResidency, Internal Medicine, 1995 - 1998
- Weill Cornell MedicineClass of 1995
Certifications & Licensure
- MD State Medical License 1998 - 2026
- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 2012
Publications & Presentations
PubMed
- 1669 citationsLatent infection of CD4 + T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapyDiana Finzi, Joel N. Blankson, Janet M. Siliciano, Joseph B. Margolick, Karen Chadwick
Nature Medicine. 1999-05-01 - 10 citationsAdaptive immune responses in vaccinated patients with symptomatic SARS-CoV-2 Alpha infection.Han-Sol Park, Janna R Shapiro, Ioannis Sitaras, Bezawit A Woldemeskel, Caroline C Garliss
JCI Insight. 2022-03-08 - 1072 citationsReplication-Competent Noninduced Proviruses in the Latent Reservoir Increase Barrier to HIV-1 CureYa Chi Ho, Liang Shan, Nina N. Hosmane, Jeffrey C. Wang, Sarah B. Laskey
Cell. 2013-10-24
Journal Articles
- Interferon-Α Enhances NK Cell Function and the Suppressive Capacity of HIV-Specific CD8+ T CellsJoel Blankson, MD, mBio
- CMPK2 and BCL-G Are Associated with Type 1 Interferon–Induced HIV Restriction in HumansJustin R. Bailey, Joel N. Blankson, Robert F. Siliciano, Stuart C. Ray, Ramy El-Diwany, Science Magazine
- Highly Attenuated Infection with a Vpr-Deleted Molecular Clone of HIV-1Peter A Anton, Jennifer A Fulcher, Otto O Yang, Joel N Blankson, The Journal of Infectious Diseases
Press Mentions
- Breakthrough COVID Infections More Likely in People Living with HIVJune 9th, 2022
- Antibodies from Covid Vaccines May Be Weaker Against Omicron, Study FindsApril 27th, 2022
- Why Breakthrough COVID? Antibodies Fighting Original Virus May Be Weaker Against OmicronApril 26th, 2022
- Join now to see all
Grant Support
- CD8+ T Cell Mediated Inhibition Of HIV-1 Replication In Elite SuppressorsNational Institute Of Allergy And Infectious Diseases2009–2012
- Analysis Of HIV-1 In Mucosal Tissue In Elite SuppressorsNational Institute Of Allergy And Infectious Diseases2011
- Characterization Of HIV Excape Mutants And T Cell Responses In Elite SuppressorsNational Institute Of Allergy And Infectious Diseases2007
- Latent Virus And HIV-1 Specific Immunity In LtnpsNational Institute Of Allergy And Infectious Diseases2002–2006
- Latency &Cell Distribution Of Virus In HIV1 InfectionNational Institute Of Allergy And Infectious Diseases1998–2000
- Minority Predoctoral Fellowship ProgramNational Institute Of General Medical Sciences1991–1992
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/joel-blankson
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: